Antidepressant-Associated Mania and Psychosis Resulting in Psychiatric Admissions
J Clin Psychiatry 2001;62(1):30-33
© Copyright 2017 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Background: The safety and tolerability of the
selective serotonin reuptake inhibitors and the newer atypical
agents have led to a significant increase in antidepressant use.
These changes raise concern as to the likelihood of a
corresponding increase in adverse behavioral reactions
attributable to these drugs.
Method: All admissions to a university-based
general hospital psychiatric unit during a 14-month period were
Results: Forty-three (8.1%) of 533 patients were
found to have been admitted owing to antidepressant-associated
mania or psychosis.
Conclusion: Despite the positive changes in the
side effect profile of antidepressant drugs, the rate of
admissions due to antidepressant-associated adverse behavioral
effects remains significant.